Matairesinol inhibits angiogenesis via suppression of mitochondrial reactive oxygen species

Biochemical and Biophysical Research Communications

Volumn 421, Issue 1, 2012, Pages 76-80

  Lee, Boram ^a   Kim, Ki Hyun ^a   Jung, Hye Jin ^a   Kwon, Ho Jeong ^a  

^a Yonsei University   (South Korea)

Author keywords

Angiogenesis; Cell based screening; Matairesinol; Mitochondrial ROS

Indexed keywords

ANGIOGENESIS INHIBITOR; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATAIRESINOL; REACTIVE OXYGEN METABOLITE; RECOMBINANT VASCULOTROPIN; RETINOIC ACID;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CHEMICAL STRUCTURE; CHORIOALLANTOIS; DRUG SCREENING; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; HELA CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRION; PRIORITY JOURNAL; UMBILICAL VEIN; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; CEDRUS; FURANS; HELA CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIGNANS; MITOCHONDRIA; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PLANT EXTRACTS; PROTEIN STABILITY; REACTIVE OXYGEN SPECIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84860338687     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.114     Document Type: Article

References (17)

1. Battegay E.J. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J. Mol. Med. (Berl.) 1995, 73:333-346.
2. Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr. Opin. Cell Biol. 2009, 21:894-899.
3. Rowinsky E.K. Clinical pharmacology of Taxol. J. Natl. Cancer Inst. Monogr. 1993, 25-37.
4. Saville M.W., Lietzau J., Pluda J.M., Feuerstein I., Odom J., Wilson W.H., Humphrey R.W., Feigal E., Steinberg S.M., Broder S., et al. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 1995, 346:26-28.
5. Perez E.A. Paclitaxel in breast cancer. Oncologist 1998, 3:373-389.
6. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol. 2002, 3:364-373.
7. Tiwari A.K., Srinivas P.V., Kumar S.P., Rao J.M. Free radical scavenging active components from Cedrus deodara. J. Agric. Food Chem. 2001, 49:4642-4645.
8. Kim N.H., Pham N.B., Quinn R.J., Kwon H.J. R-(-)-beta-O-methylsynephrine, a natural product, inhibits VEGF-induced angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 2010, 399:20-23.
9. Kim K.H., Park J.Y., Jung H.J., Kwon H.J. Identification and biological activities of a new antiangiogenic small molecule that suppresses mitochondrial reactive oxygen species. Biochem. Biophys. Res. Commun. 2011, 404:541-545.
10. Jung H.J., Shim J.S., Lee J., Song Y.M., Park K.C., Choi S.H., Kim N.D., Yoon J.H., Mungai P.T., Schumacker P.T., Kwon H.J. Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing. J. Biol. Chem. 2010, 285:11584-11595.
11. Kim Y., Jung H.J., Kwon H.J. A natural small molecule voacangine inhibits angiogenesis both in vitro and in vivo. Biochem. Biophys. Res. Commun. 2012, 417:330-334.
12. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987, 47:3239-3245.
13. Shim J.S., Kim J.H., Cho H.Y., Yum Y.N., Kim S.H., Park H.J., Shim B.S., Choi S.H., Kwon H.J. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin. Chem. Biol. 2003, 10:695-704.
14. Jung H.J., Kim J.H., Shim J.S., Kwon H.J. A novel Ca2+/calmodulin antagonist HBC inhibits angiogenesis and down-regulates hypoxia-inducible factor. J. Biol. Chem. 2010, 285:25867-25874.
15. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
16. Brahimi-Horn M.C., Chiche J., Pouyssegur J. Hypoxia and cancer. J. Mol. Med. 2007, 85:1301-1307.
17. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., Mansfield K.D., Simon M.C., Hammerling U., Schumacker P.T. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005, 1:401-408.